Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Plasmodium falciparum endoplasmic reticulum (ER) protein transport system is a specialized multi-protein machinery responsible for the translocation and processing of proteins destined for the parasite's organelles or export into the host erythrocyte [8, 13]. A central component of this system is the Sec61-Plasmepsin V translocon complex, which facilitates the co-translational entry of proteins into the ER lumen [8, 30]. Within this complex, the aspartyl protease Plasmepsin V (PMV) acts as a critical gatekeeper by recognizing and cleaving the Plasmodium export element (PEXEL) motif, a step essential for the export of approximately 10% of the parasite's proteome [20, 25]. These exported proteins are vital for remodeling the host red blood cell, establishing nutrient uptake channels, and evading the host immune system through the display of virulence factors like PfEMP1 [11, 21]. Because the system is essential for both asexual replication and the development of sexual stages (gametocytes), it represents a high-value target for antimalarial drug discovery [22, 23]. Small molecule inhibitors targeting Plasmepsin V, such as the WEHI series, have demonstrated potent antimalarial activity by blocking protein export and arresting parasite growth [20, 30]. However, achieving selectivity over human ER transport machinery and related proteases remains a significant therapeutic challenge [19, 29].
Inhibition of Plasmepsin V-mediated PEXEL cleavage, blockade of Sec61-mediated protein translocation, and inhibition of ER-to-Golgi vesicular trafficking.
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Plasmodium falciparum endoplasmic reticulum protein transport system.